AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 93 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.17 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $43,000 | -27.1% | 27,000 | 0.0% | 0.01% | -16.7% |
| Q3 2018 | $59,000 | -31.4% | 27,000 | -28.9% | 0.01% | -25.0% |
| Q2 2018 | $86,000 | +6.2% | 38,000 | +35.7% | 0.02% | 0.0% |
| Q1 2018 | $81,000 | +15.7% | 28,000 | +12.0% | 0.02% | +23.1% |
| Q4 2017 | $70,000 | -23.1% | 25,000 | 0.0% | 0.01% | -27.8% |
| Q3 2017 | $91,000 | -68.5% | 25,000 | -75.0% | 0.02% | -67.3% |
| Q2 2017 | $289,000 | – | 100,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |